CD276 and glioma: The results of our investigation showed a strong relationship between the expression of SMARCAL1 and several immune checkpoint genes, including CD276, NRP1, TNFSF4, CD40, CD200, and CD80 in Glioma, LUAD, LIHC, KIRC, and UCEC.